Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Retinoic Acid Receptor beta Antibodies:
anti-Mouse (Murine) Retinoic Acid Receptor beta Antibodies:
anti-Rat (Rattus) Retinoic Acid Receptor beta Antibodies:
Go to our pre-filtered search.
Human Monoclonal Retinoic Acid Receptor beta Primary Antibody for WB - ABIN152364
Klaassen, Brakenhoff, Smeets, Snow, Braakhuis: Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines. in International journal of cancer. Journal international du cancer 2001
Show all 3 Pubmed References
Human Monoclonal Retinoic Acid Receptor beta Primary Antibody for EMSA, IHC - ABIN2668691
Chakravarti, Mathur, Bahadur, Shukla, Rochette-Egly, Ralhan: Expression of RARalpha and RARbeta in human oral potentially malignant and neoplastic lesions. in International journal of cancer. Journal international du cancer 2001
Show all 2 Pubmed References
Human Polyclonal Retinoic Acid Receptor beta Primary Antibody for IHC (p) - ABIN2476325
Haraguchi, Liu, Cianciolo, Good, Day: Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. in Cellular immunology 1992
Show all 3 Pubmed References
Human Polyclonal Retinoic Acid Receptor beta Primary Antibody for ICC, IF - ABIN4349385
Seidensaal, Nollert, Feige, Muller, Fleming, Gunkel, Zaoui, Grabe, Weichert, Weber, Plinkert, Simon, Hess et al.: Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell ... in Molecular cancer 2015
Bat Polyclonal Retinoic Acid Receptor beta Primary Antibody for ELISA, IHC (p) - ABIN4349383
Fabricius, Kruse-Boitschenko, Schneeweiss, Wildner, Hoffmeister, Raguse: Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention. in International journal of oncology 2011
Study identified a novel mutation in RARB gene in patients with intellectual disability and progressive motor impairment which confers gain-of-function further promoting the retinoic acid (RA) ligand-induced transcriptional activity by twofold to threefold over the wild-type receptor. These results providing novel insight into the role of RA in neural networks in humans.
mRNAs expression and methylation pattern of RARB, NR4A1 (show NR4A1 Antibodies) and HSD3B2 (show HSD3B2 Antibodies) genes in human adrenal tissues (HAT (show MGEA5 Antibodies)) and in pediatric virilizing adrenocortical tumors (VAT) were analyzed.
RARb and FHIT promoter methylation may be associated with the carcinogenesis of cervical cancer. FHIT promoter methylation may play a crucial role in cervical cancer progression. Additional studies with large sample sizes are essential to confirm our findings.
Upregulation of RARB enhances the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents in vitro.
Lack of RARbeta nuclear expression is associated with Non-small cell lung cancer development and associated with a worse prognosis.
methylated promoters of DAPK1 (show DAPK1 Antibodies) combined with MGMT (show MGMT Antibodies), MGMT (show MGMT Antibodies) combined with RARB, DAPK1 (show DAPK1 Antibodies) combined with RARB were positive correlated with cervical disease grade
Overexpression of miR (show MLXIP Antibodies)-146a-5p and miR (show MLXIP Antibodies)-146b-5p caused a 31% and 33% decrease in endogenous RARB mRNA levels.
shows that RAR-beta methylation detected in lung tissue may be used as a predictive marker for non-small cell lung cancer diagnosis and that APC (show APC Antibodies) methylation in tumor sample may be a useful marker
RARbeta2 methylation is significantly increased in breast cancer samples when compared to non-cancerous controls
Whole-exome sequencing in a South American cohort links ALDH1A3, FOXN1 and RARB/retinoic acid regulation pathways to autism s (show ALDH1A3 Antibodies)pectrum di (show FOXN1 Antibodies)sorders.
the low expression of RARbeta, may induce the down regulation of p16(INK4a (show CDKN2A Antibodies)), chronic inflammation and decreased apoptosis and may be involved in vulnerability to HR-HPV and early stage cervical carcinogenesis.
Upregulation of Rarb increases the cytotoxic effect of 5-FU on xenografted cholangiocarcinoma tumors.
Results found that HPV16 E7 increases RARB mRNA and protein expression both in vitro and in the cervix of young K14E7 transgenic mice suggesting that RARB overexpression is part of the early molecular events induced by the E7 oncoprotein.
Chromatin immunoprecipitation assay using RarB as the immunoprecipitation target suggests retinoic acid regulation of Aldh1a3 (show ALDH1A3 Antibodies) and Foxn1 (show FOXN2 Antibodies) in mice.
IL-15 (show IL15 Antibodies) specifically down-regulates RARB expression, and RARB may play a protective role in lung injury caused by smoking or viral infections.
RARB hypermethylation was involved in the areca-associated oral carcinogenesis.
Report liver RAR-beta mediated response to retinoic acid.
Data indicate that all three retinoic acid receptor (show RARA Antibodies) isoforms RARalha, RARbeta and RARgamma are expressed in naive CD8 (show CD8A Antibodies)+ T cells, as well as CD8 (show CD8A Antibodies)+ T cells activated for 48 or 72 h.
RARbeta is essential for differentiation of ES cells to pancreatic endocrine cells.
Retinoic acid receptor beta stimulates hepatic induction of fibroblast growth factor 21 (show FGF21 Antibodies) to promote fatty acid oxidation and control whole-body energy homeostasis in mice.
This gene encodes retinoic acid receptor beta, a member of the thyroid-steroid hormone receptor superfamily of nuclear transcriptional regulators. This receptor localizes to the cytoplasm and to subnuclear compartments. It binds retinoic acid, the biologically active form of vitamin A which mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation. It is thought that this protein limits growth of many cell types by regulating gene expression. The gene was first identified in a hepatocellular carcinoma where it flanks a hepatitis B virus integration site. The gene expresses at least two transcript variants\; one additional transcript has been described, but its full length nature has not been determined.
retinoic acid receptor, beta
, retinoic acid receptor beta
, retinoic acid receptor beta-like
, HBV-activated protein
, hepatitis B virus activated protein
, nuclear receptor subfamily 1 group B member 2
, retinoic acid receptor beta 2
, retinoic acid receptor beta 4
, retinoic acid receptor beta 5
, retinoic acid receptor beta variant 1
, retinoic acid receptor beta variant 2
, retinoic acid receptor, beta polypeptide
, RAR beta 2
, retinoic acid receptor beta 1/ beta 3
, retinoic acid receptor beta4'
, retinoic acid receptor-beta